UPLOAD Filing
REGENXBIO Inc.
Date: June 20, 2025 · CIK: 0001590877 · Accession: 0000000000-25-006467
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-288053
Letter
Re: REGENXBIO Inc. Registration Statement on Form S-3 Filed June 13, 2025 File No. 333-288053 Dear Curran Simpson:
June 20, 2025
Curran Simpson Chief Executive Officer REGENXBIO Inc. 9804 Medical Center Drive Rockville, MD 20850
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Doris Stacey Gama at 202-551-3188 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Matthew C. Franker, Esq.
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> June 20, 2025 Curran Simpson Chief Executive Officer REGENXBIO Inc. 9804 Medical Center Drive Rockville, MD 20850 Re: REGENXBIO Inc. Registration Statement on Form S-3 Filed June 13, 2025 File No. 333-288053 Dear Curran Simpson: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Doris Stacey Gama at 202-551-3188 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Matthew C. Franker, Esq. </TEXT> </DOCUMENT>